Pregabalin
Lyrica, Lyrica CR
Anticonvulsant / Neuropathic Pain Agent
NADAC/unit
$0.0458
No Shortage
Tier 1: 263.8%
PA Req: 181.5%
28 Manufacturers
192 ANDAs
indicated for: Management of neuropathic pain associated with diabetic peripheral neuropathy Management of postherpetic neuralgia Adjunctive therapy for the treatment of partial-onset seizures in p....
vs. brand Lyrica: Generic saves up to 100% per unit
Market Intelligence
2024-06-12 Class III Recall: Rising Pharma Holding, Inc.
Generic Manufacturers
ADAPTIS PHARMA PRIVATE LTDAIPING PHARMACEUTICAL INCALEMBIC PHARMACEUTICALS LTDALKEM LABORATORIES LTDAMNEAL PHARMACEUTICALS CO GMBHANDA REPOSITORY LLCAUROBINDO PHARMA LTDCHANGZHOU PHARMACEUTICAL FACTORYCHARTWELL RX SCIENCES LLCCREEKWOOD PHARMACEUTICALS LLCDR REDDYS LABORATORIES LTDEPIC PHARMA LLCESKAYEF PHARMACEUTICALS LTDFOURRTS INDIA LABORATORIES PRIVATE LTDHETERO LABS LTD UNIT IIIINVAGEN PHARMACEUTICALS INCJUBILANT GENERICS LTDMSN LABORATORIES PRIVATE LTDPHARMOBEDIENT CONSULTING LLCPRINSTON PHARMACEUTICAL INCREGCON HOLDINGS LLCRENATA PLCRISING PHARMA HOLDINGS INCRUBICON RESEARCH LTDSCIEGEN PHARMACEUTICALS INCSTRIDES PHARMA GLOBAL PTE LTDTORRENT PHARMACEUTICALS LTDUPJOHN US 2 LLCYILING PHARMACEUTICAL LTD
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.